Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Nucl Med ; 40(9): 1434-40, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10492361

ABSTRACT

UNLABELLED: In this study, we compared 99mTc-methoxyisobutyl isonitrile (MIBI) with 201Tl scintigraphy for the detection of residual thyroid cancer not found by 131I scans in patients with increased risk of recurrence after 131I therapy. METHODS: 201Tl and MIBI scans were obtained in 54 patients with negative 131I scans 3-25 y (median 7.9 y) after the first postsurgical 131I therapy. Serum thyroglobulin (Tg) levels were measured while patients were receiving thyroid hormone and again 6 wk after withdrawal of hormone therapy. RESULTS: The overall results were the same for both 201Tl and MIBI imaging, with a sensitivity of 19 of 36 (53%), specificity of 17 of 17 (100%) and accuracy of 36 of 54 (69%). Planar images missed residual cancer in high cervical lymph nodes adjacent to salivary gland activity, in small nodes (<1 cm) deep in the neck or chest and with diffuse pulmonary micrometastases. Serum Tg was elevated in 24 of 36 (67%) patients with residual cancer; 201Tl detected tumor sites in 13 of 24 (54%) of these patients, and MIBI detected tumor sites in 14 of 24 (58%) of these patients. Of the 12 patients who had residual cancer and false-negative serum Tg levels, 6 had true-positive 201Tl and 5 had true-positive MIBI scans. CONCLUSION: 201Tl and MIBI planar imaging yield the same high specificity and positive predictive value for residual thyroid cancer in patients with high-risk profiles and negative radioiodide scans. Both imaging agents detected residual cancer in more than half of the patients in whom conventional staging techniques did not reliably detect either the presence or the extent of residual thyroid cancer and changed the management in patients with surgically resectable cancer.


Subject(s)
Carcinoma, Papillary/diagnostic imaging , Carcinoma, Papillary/secondary , Iodine Radioisotopes/therapeutic use , Radiopharmaceuticals , Technetium Tc 99m Sestamibi , Thallium Radioisotopes , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/radiotherapy , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Papillary/radiotherapy , Carcinoma, Papillary/surgery , Female , Humans , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis , Male , Middle Aged , Neoplasm, Residual , Predictive Value of Tests , Radionuclide Imaging , Retrospective Studies , Risk Factors , Sensitivity and Specificity , Thyroglobulin/blood , Thyroid Neoplasms/pathology , Thyroid Neoplasms/surgery , Thyroidectomy
3.
J Bone Joint Surg Am ; 69(2): 255-9, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3805087

ABSTRACT

In a prospective study in which we attempted to identify the etiology of postoperative ulnar-nerve palsy, 6,538 patients were followed through surgery and convalescence. In seventeen patients (0.26 per cent), an ulnar-nerve palsy developed at varying times during the postoperative period. Of these seventeen patients, all were re-evaluated at an average of six months and eleven were re-evaluated at an average of three and one-half years after operation. Bilateral nerve-conduction studies were done on all seventeen patients during the initial visit and on five of the eleven who were re-evaluated at an average of three and one-half years. Abnormal slowing of the conduction times was found in both nerves, suggesting a possible predisposition to this condition. Based on the results of the study, it is suggested that many patients may have a subclinical ulnar neuropathy that may become symptomatic as a result of the many maneuvers and manipulations that are associated with surgical procedures.


Subject(s)
Paralysis/diagnosis , Postoperative Complications/diagnosis , Ulnar Nerve , Adult , Aged , Female , Humans , Male , Middle Aged , Neural Conduction , Paralysis/physiopathology , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...